Related Experiment Video
Updated: Feb 21, 2026
09:53
Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
867
[Herbal supplement usage in cardiac patients]
Neslihan Pınar1, Meyli Topaloğlu, Cahit Özer
1Department of Medical Pharmacology, Mustafa Kemal University Faculty of Medicine, Hatay, Turkey. drnesli01@gmail.com.
Summary
Many cardiac patients use herbal products, but most do not inform their doctors. This lack of communication regarding complementary and alternative medicine (CAM) use can lead to potential health risks.
Area of Science:
- Cardiology
- Pharmacology
- Integrative Medicine
Background:
- Complementary and alternative medicine (CAM) use is increasing globally.
- CAM encompasses a wide range of practices outside standard medical care.
- Herbal medicinal products are a common form of CAM.
Purpose of the Study:
- To investigate the prevalence of herbal product use among cardiac patients.
- To identify the specific herbal products used by cardiac patients.
- To understand the methods of administration and physician consultation patterns for herbal products in this population.
Main Methods:
- A descriptive, cross-sectional study was conducted.
- 199 cardiac patients over 18 years old participated.
- Data were collected via a 20-item survey between April and June 2016.
Main Results:
- 28.6% of cardiac patients reported using herbal products.
- 85.9% of herbal product users did not consult their physician.
- Commonly used products included lemon, pomegranate syrup, green tea, ginger, and sage, particularly among patients with hypertension and cardiovascular diseases.
Conclusions:
- A significant proportion of cardiac patients use herbal medicinal supplements.
- The majority of patients do not disclose their herbal product use to healthcare providers.
- Non-disclosure of herbal product use poses a risk for adverse events and drug interactions.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
1.6K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.6K
01:22Heart Failure VI: Adjunct Therapies
430
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
430
01:30Heart Failure V: Medical Management
392
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
392
01:22Heart Failure Drugs: β-Blockers
1.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
01:29Cardiomyopathy VI: Nursing Management
379
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
379